Trade NERV stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Minerva Neurosciences, Inc (NERV) is trading at US$3.28, up 1.55% today as of Oct 2, 16:00 EDT. The company has a market capitalisation of US$231.1M. Over the past 52 weeks, NERV has traded between US$2.08 and US$12.46. On Syfe you can trade NERV with $0 commission and add it to your watchlist.
| Previous close | US$3.23 |
|---|---|
| Market cap | US$231.1M |
| 52-week range | US$2.08 – US$12.46 |
| Volume | 57.02K |
| Exchange | US |
Minerva Neurosciences, Inc
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey Robin Race on April 23, 2007 and is headquartered in Burlington, MA.
Year: 2014
--Jefferies Upgrades Minerva Neurosciences to Buy From Hold, Adjusts PT to $10 From $7.50
Aug 14, 11:36 AM · MT Newswires
Minerva Neurosciences, Inc (NERV) stock is trading at US$3.28, +1.55% from the previous close of US$3.23.
The market cap for Minerva Neurosciences, Inc (NERV) stock is approximately US$231.1M.
The 52-week high for Minerva Neurosciences, Inc (NERV) stock is US$12.46.
The 52-week low for Minerva Neurosciences, Inc (NERV) stock is US$2.08.
Minerva Neurosciences, Inc (NERV) does not currently pay a dividend.
Stay on top of NERV
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
